Total Payments
$28,974
2024 Payments
$229.14
Companies
59
Transactions
503
Medicare Patients
3,484
Medicare Billing
$951,459
Payment Breakdown by Category
Consulting$17,243 (59.5%)
Food & Beverage$9,052 (31.2%)
Travel$1,924 (6.6%)
Education$754.36 (2.6%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $17,243 | 7 | 59.5% |
| Food and Beverage | $9,052 | 478 | 31.2% |
| Travel and Lodging | $1,924 | 8 | 6.6% |
| Education | $754.36 | 10 | 2.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $8,064 | 41 | $0 (2023) |
| Gilead Sciences Inc | $4,520 | 12 | $0 (2017) |
| Ipsen Biopharmaceuticals, Inc | $2,128 | 3 | $0 (2021) |
| E.R. Squibb & Sons, L.L.C. | $2,063 | 24 | $0 (2023) |
| GlaxoSmithKline, LLC. | $1,950 | 1 | $0 (2020) |
| Bayer Healthcare Pharmaceuticals Inc. | $1,940 | 10 | $0 (2023) |
| Janssen Biotech, Inc. | $1,065 | 39 | $0 (2024) |
| PFIZER INC. | $916.96 | 66 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $695.45 | 35 | $0 (2023) |
| Rigel Pharmaceuticals, Inc. | $482.69 | 13 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $229.14 | 2 | Inari Medical, Inc. ($189.83) |
| 2023 | $1,604 | 79 | Janssen Biotech, Inc. ($270.67) |
| 2022 | $1,768 | 98 | AstraZeneca Pharmaceuticals LP ($247.60) |
| 2021 | $1,983 | 101 | AstraZeneca Pharmaceuticals LP ($221.02) |
| 2020 | $7,111 | 64 | Ipsen Biopharmaceuticals, Inc ($2,100) |
| 2019 | $7,595 | 8 | Novartis Pharmaceuticals Corporation ($7,535) |
| 2018 | $500.18 | 7 | Biocompatibles, Inc. ($197.88) |
| 2017 | $8,184 | 144 | Gilead Sciences Inc ($4,520) |
All Payment Transactions
503 individual payment records from CMS Open Payments — Page 1 of 21
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/14/2024 | Inari Medical, Inc. | FLOWTRIEVER CATHETER, S (Device), CT THROMBECTOMY SYSTEM KIT | Food and Beverage | In-kind items and services | $189.83 | General |
| Category: VTE | ||||||
| 01/26/2024 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $39.31 | General |
| Category: Oncology | ||||||
| 11/01/2023 | Janssen Biotech, Inc. | DARZALEX (Biological) | Education | In-kind items and services | $99.95 | General |
| Category: Oncology | ||||||
| 09/21/2023 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $23.37 | General |
| Category: ONCOLOGY | ||||||
| 09/20/2023 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $28.11 | General |
| Category: Oncology | ||||||
| 09/12/2023 | Novartis Pharmaceuticals Corporation | TABRECTA (Drug) | Food and Beverage | In-kind items and services | $17.64 | General |
| Category: Oncology | ||||||
| 09/12/2023 | Novartis Pharmaceuticals Corporation | TABRECTA (Drug) | Food and Beverage | In-kind items and services | $0.91 | General |
| Category: Oncology | ||||||
| 08/31/2023 | ARRAY BIOPHARMA INC | LORBRENA (Drug), BRAFTOVI, MEKTOVI | Food and Beverage | In-kind items and services | $19.74 | General |
| Category: ONCOLOGY | ||||||
| 08/31/2023 | ARRAY BIOPHARMA INC | BRAFTOVI (Drug), MEKTOVI | Food and Beverage | In-kind items and services | $10.00 | General |
| Category: ONCOLOGY | ||||||
| 08/29/2023 | Celgene Corporation | REBLOZYL (Biological) | Food and Beverage | Cash or cash equivalent | $7.91 | General |
| Category: Hematology | ||||||
| 08/24/2023 | Amgen Inc. | Blincyto (Biological), Kyprolis | Food and Beverage | In-kind items and services | $16.89 | General |
| Category: Oncology | ||||||
| 08/23/2023 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Food and Beverage | Cash or cash equivalent | $17.74 | General |
| Category: Oncology | ||||||
| 08/17/2023 | Astellas Pharma US Inc | Xospata (Drug) | Food and Beverage | In-kind items and services | $20.16 | General |
| Category: Oncology | ||||||
| 08/15/2023 | Pharmacosmos Therapeutics Inc. | MONOFERRIC (Drug) | Food and Beverage | In-kind items and services | $22.54 | General |
| Category: HEMATOLOGY | ||||||
| 08/11/2023 | Bayer Healthcare Pharmaceuticals Inc. | Nubeqa (Drug), Xofigo | Food and Beverage | In-kind items and services | $24.66 | General |
| Category: Oncology | ||||||
| 08/09/2023 | Exelixis Inc. | CABOMETYX (Drug) | Food and Beverage | Cash or cash equivalent | $16.82 | General |
| Category: Oncology | ||||||
| 08/08/2023 | Exelixis Inc. | CABOMETYX (Drug) | Food and Beverage | Cash or cash equivalent | $1.27 | General |
| Category: Oncology | ||||||
| 08/03/2023 | Rigel Pharmaceuticals, Inc. | Rezlidhia (Drug), Tavalisse | Food and Beverage | Cash or cash equivalent | $33.98 | General |
| Category: Acute Myeloid Leukemia | ||||||
| 08/03/2023 | Rigel Pharmaceuticals, Inc. | Rezlidhia (Drug), Tavalisse | Food and Beverage | Cash or cash equivalent | $2.71 | General |
| Category: Acute Myeloid Leukemia | ||||||
| 08/01/2023 | PFIZER INC. | BOSULIF (Drug) | Food and Beverage | In-kind items and services | $23.04 | General |
| Category: METABOLIC DISEASE;ONCOLOGY | ||||||
| 07/27/2023 | Novartis Pharmaceuticals Corporation | TABRECTA (Drug) | Food and Beverage | In-kind items and services | $19.89 | General |
| Category: Oncology | ||||||
| 07/27/2023 | Novartis Pharmaceuticals Corporation | TABRECTA (Drug) | Food and Beverage | In-kind items and services | $1.54 | General |
| Category: Oncology | ||||||
| 07/20/2023 | Celgene Corporation | Pomalyst (Drug) | Food and Beverage | Cash or cash equivalent | $17.64 | General |
| Category: Hematology | ||||||
| 07/20/2023 | Celgene Corporation | Pomalyst (Drug) | Food and Beverage | Cash or cash equivalent | $15.26 | General |
| Category: Hematology | ||||||
| 07/19/2023 | AstraZeneca Pharmaceuticals LP | TAGRISSO (Drug) | Food and Beverage | In-kind items and services | $24.88 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 609 | 5,135 | $635,776 | $182,854 |
| 2022 | 17 | 962 | 9,087 | $939,127 | $278,741 |
| 2021 | 14 | 862 | 8,001 | $718,547 | $250,052 |
| 2020 | 17 | 1,051 | 6,888 | $395,851 | $239,812 |
Total Patients
3,484
Total Services
29,111
Medicare Billing
$951,459
Procedure Codes
62
All Medicare Procedures & Services
62 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0897 | Injection, denosumab, 1 mg | Office | 2023 | 11 | 2,701 | $229,500 | $49,170 | 21.4% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 55 | 465 | $58,125 | $42,851 | 73.7% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 46 | 531 | $53,100 | $32,600 | 61.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 104 | 333 | $171,041 | $29,294 | 17.1% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 54 | 59 | $14,273 | $7,967 | 55.8% |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | Office | 2023 | 11 | 70 | $40,950 | $6,319 | 15.4% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 106 | 317 | $3,522 | $2,544 | 72.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 14 | 20 | $15,027 | $2,444 | 16.3% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2023 | 12 | 51 | $13,714 | $2,413 | 17.6% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 106 | 314 | $8,951 | $2,351 | 26.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 17 | 17 | $10,132 | $1,984 | 19.6% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 39 | 151 | $8,116 | $1,531 | 18.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 11 | 11 | $7,424 | $1,274 | 17.2% |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 2023 | 23 | 95 | $1,900 | $112.84 | 5.9% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 129 | 910 | $113,750 | $72,781 | 64.0% |
| J0897 | Injection, denosumab, 1 mg | Office | 2022 | 12 | 3,960 | $276,449 | $61,628 | 22.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 122 | 449 | $236,163 | $43,417 | 18.4% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 153 | 205 | $46,125 | $31,611 | 68.5% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 49 | 530 | $53,000 | $29,571 | 55.8% |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | Office | 2022 | 14 | 85 | $51,037 | $9,123 | 17.9% |
| 96367 | Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | Office | 2022 | 18 | 282 | $36,096 | $6,631 | 18.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 31 | 44 | $35,320 | $6,180 | 17.5% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2022 | 20 | 86 | $25,456 | $4,669 | 18.3% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 24 | 24 | $26,298 | $3,706 | 14.1% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2022 | 131 | 476 | $12,664 | $3,605 | 28.5% |
About Dr. Archana Maini, M.D
Dr. Archana Maini, M.D is a Hematology & Oncology healthcare provider based in Fort Lauderdale, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/10/2006. The National Provider Identifier (NPI) number assigned to this provider is 1942211370.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Archana Maini, M.D has received a total of $28,974 in payments from pharmaceutical and medical device companies, with $229.14 received in 2024. These payments were reported across 503 transactions from 59 companies. The most common payment nature is "Consulting Fee" ($17,243).
As a Medicare-enrolled provider, Maini has provided services to 3,484 Medicare beneficiaries, totaling 29,111 services with total Medicare billing of $951,459. Data is available for 4 years (2020–2023), covering 62 distinct procedure/service records.
Ad
Practice Information
- Specialty Hematology & Oncology
- Other Specialties Hospice and Palliative Medicine
- Location Fort Lauderdale, FL
- Active Since 08/10/2006
- Last Updated 04/05/2024
- Taxonomy Code 207RH0003X
- Entity Type Individual
- NPI Number 1942211370
Products in Payments
- ADAKVEO (Biological) $7,124
- Zydelig (Drug) $4,479
- ONIVYDE (Drug) $2,100
- OPDIVO (Biological) $2,028
- Stivarga (Drug) $935.23
- Vitrakvi (Drug) $900.00
- IMBRUVICA (Drug) $517.94
- Tavalisse (Drug) $446.00
- KEYTRUDA (Biological) $368.40
- IBRANCE (Drug) $305.05
- DARZALEX (Biological) $291.63
- Xtandi (Drug) $269.76
- Lenvima (Drug) $253.76
- TAGRISSO (Drug) $226.21
- XTANDI (Drug) $216.46
- ERLEADA (Drug) $213.43
- ADCETRIS (Biological) $195.35
- FLOWTRIEVER CATHETER, S (Device) $189.83
- CALQUENCE (Drug) $172.30
- BOSULIF (Drug) $162.55
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hematology & Oncology Doctors in Fort Lauderdale
Dr. Edgardo Santos, Md, MD
Hematology & Oncology — Payments: $2.1M
Hematology & Oncology $2.1M
Dr. Georges Azzi, M.d, M.D
Hematology & Oncology — Payments: $111,744
Hematology & Oncology $111,744
Dr. Evan Wu, Md, MD
Hematology & Oncology — Payments: $53,219
Hematology & Oncology $53,219
David Drew, M.d, M.D
Hematology & Oncology — Payments: $8,758
Hematology & Oncology $8,758
Dr. Tricia Kalwar, Md, MD
Hematology & Oncology — Payments: $2,904
Hematology & Oncology $2,904
Dr. Jeffrey Weisberg, D.o, D.O
Hematology & Oncology — Payments: $15.27
Hematology & Oncology $15.27